Semaglutide

Semaglutide is a glucagon-like peptide-1 receptor agonist. It is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management. Semaglutide is not for use in people with type 1 diabetes. Semaglutide is indicated as an adjunct to diet and exercise to improve glycemic control in patients. The higher-dose formulation of Semaglutide is indicated as an adjunct to diet and exercise for long-term weight management in adults with obesity (initial body mass index (BMI) ≥ 30 kg/m2) or who are overweight (initial BMI ≥ 27 kg/m2) and have at least one weight-related comorbidity.

IF NO TYPE 2 DIABETES - 1 injection per week

1-2 weeks 0.25 mg

3-4 weeks 0.5 mg

5-8 weeks 1 mg

From the 9th week, if necessary, it can be increased to 2 mg if there are no side effects

FOR TYPE 2 DIABETES - 1 injection per week

1-4 weeks 0.25 mg

5-8 weeks 0.5 mg

9-12 weeks 1 mg

13+ weeks 2 mg

Inject into your abdomen, thigh or upper arm

Semaglutide reduces high blood sugar by increasing the amount of insulin released, decreasing the amount of glucagon released, and delaying gastric emptying. Semaglutide also controls appetite and helps reduce the amount of food a person wants to eat. In addition, Semaglutide reduces preference for high-fat meals.

In clinical studies, Semaglutide had a positive effect on plasma lipids, reduced systolic blood pressure and reduced inflammation. In animal studies, Semaglutide slowed the development of atherosclerosis by preventing the progression of aortic plaque development and reducing plaque inflammation.

Tell your doctor if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, hoarseness, or shortness of breath.

You should not use Semaglutide if you have multiple endocrine neoplasia type 2 (tumors in the glands) or a personal or family history of medullary thyroid cancer.

Ask your doctor about taking Semaglutide if you have ever had the following diseases or conditions:
diabetic ketoacidosis
pancreatitis;
kidney disease
eye problems caused by diabetes (retinopathy).